Side effects of COVID-19 vaccine in patients. Ambato, Ecuador
DOI:
https://doi.org/10.35381/s.v.v6i3.2295Keywords:
Adverse effects, Viral Vaccines, immunology. (Source, DeCS).Abstract
Objective: To know the side effects in people caused by the COVID19 vaccine. Method: observational descriptive. Results: 2.44% (n=4) of women chose the first dose, 23.78% (n=39) of women chose the second dose, 60.37% (n=99) chose the third dose and 13.41% (n=22) chose the fourth dose. No statistically significant differences were found (p >0.05). Conclusion: When the COVID-19 vaccine (AstraZeneca, Pfizer, Sinovac, etc.) is administered, it can cause several adverse effects such as headache, muscle, joint or injection site pain, tiredness, chills, fever and swelling at the injection site, nausea, but it was also analyzed that not all people can present symptoms.
Downloads
References
Knoll MD, Wonodi C. Oxford-AstraZeneca COVID-19 vaccine efficacy. Lancet. 2021;397(10269):72-74. doi:10.1016/S0140-6736(20)32623-4
Chagla Z. In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose. Ann Intern Med. 2021;174(3):JC29. doi:10.7326/ACPJ202103160-029
Luxi N, Giovanazzi A, Capuano A, et al. COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety. Drug Saf. 2021;44(12):1247-1269. doi:10.1007/s40264-021-01131-6
Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. 2021;21(10):626-636. doi:10.1038/s41577-021-00592-1
Wack S, Patton T, Ferris LK. COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence. J Am Acad Dermatol. 2021;85(5):1274-1284. doi:10.1016/j.jaad.2021.07.054
Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong LP. Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China. PLoS Negl Trop Dis. 2020;14(12):e0008961. Published 2020 Dec 17. doi:10.1371/journal.pntd.0008961
Kostoff RN, Briggs MB, Porter AL, Spandidos DA, Tsatsakis A. [Comment] COVID 19 vaccine safety. Int J Mol Med. 2020;46(5):1599-1602. doi:10.3892/ijmm.2020.4733
Barbari A. COVID-19 Vaccine Concerns: Fact or Fiction?. Exp Clin Transplant. 2021;19(7):627-634. doi:10.6002/ect.2021.0056
Shakoor MT, Birkenbach MP, Lynch M. ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine. Am J Kidney Dis. 2021;78(4):611-613. doi:10.1053/j.ajkd.2021.06.016
Li M, Wang H, Tian L, et al. COVID-19 vaccine development: milestones, lessons and prospects. Signal Transduct Target Ther. 2022;7(1):146. Published 2022 May 3. doi:10.1038/s41392-022-00996-y
Schaler L, Wingfield M. COVID-19 vaccine - can it affect fertility?. Ir J Med Sci. 2022;191(5):2185-2187. doi:10.1007/s11845-021-02807-9
Hause AM, Baggs J, Marquez P, et al. COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(5152):1755-1760. Published 2021 Dec 31. doi:10.15585/mmwr.mm705152a1
Tarawneh O, Tarawneh H. Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine. Am J Hematol. 2021;96(5):E133-E134. doi:10.1002/ajh.26106
Waheed W, Carey ME, Tandan SR, Tandan R. Post COVID-19 vaccine small fiber neuropathy. Muscle Nerve. 2021;64(1):E1-E2. doi:10.1002/mus.27251
Franchini M, Liumbruno GM, Pezzo M. COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new syndrome. Eur J Haematol. 2021;107(2):173-180. doi:10.1111/ejh.13665
Published
How to Cite
Issue
Section
License
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
